NDC 0169-7903
REBINYN
(coagulation Factor Ix (recombinant), Glycopegylated)
REBINYN is a Kit in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is .
| Product ID | 0169-7903_34422170-df50-4547-9a46-ecd0a03af07d |
| NDC | 0169-7903 |
| Product Type | Human Prescription Drug |
| Proprietary Name | REBINYN |
| Generic Name | (coagulation Factor Ix (recombinant), Glycopegylated) |
| Dosage Form | Kit |
| Marketing Start Date | 2022-08-11 |
| Marketing Category | BLA / |
| Application Number | BLA125611 |
| Labeler Name | Novo Nordisk |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 0169-7903-01
1 KIT in 1 KIT (0169-7903-01) * 4 mL in 1 VIAL, GLASS (0169-7933-11) * 4 mL in 1 SYRINGE, GLASS (0169-7009-98)
| Marketing Start Date | 2022-08-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "REBINYN" or generic name "(coagulation Factor Ix (recombinant), Glycopegylated)"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-7901 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
| 0169-7902 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
| 0169-7903 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
| 0169-7905 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
Trademark Results [REBINYN]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REBINYN 79156280 4714544 Live/Registered |
Novo Nordisk Health Care AG 2014-07-14 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.